Receptors for Somatostatin and Somatostatin Analogues in Human Breast Tumors^a

This publication has 28 references indexed in Scilit:

• Somatostatin receptor‐positive primary breast tumors: Genetic, patient and tumor characteristics
  International Journal of Cancer, 1993
• Somatostatin receptor subtype gene expression in human and rodent tumors
  Life Sciences, 1993
• A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumours
  European Journal Of Cancer, 1993
• Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients
  Breast Cancer Research and Treatment, 1990
• Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin
  Breast Cancer Research and Treatment, 1989
• Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer
  Breast Cancer Research and Treatment, 1989
• The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer
  Cancer, 1989
• Characteristics and distribution of receptors for [d‐trp⁶]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer
  Journal of Clinical Laboratory Analysis, 1989
• Differential Binding of Somatostatin Agonists to Somatostatin Receptors in Brain and Adenohypophysis
  Neuroendocrinology, 1987